Genetic Dysfunctions of the Surfactant System in Children: Results of a Multicenter Study
https://doi.org/10.31550/1727-2378-2023-22-3-22-31
Abstract
Aim: Genetic, clinical, laboratory-instrumental and morphological characteristics of genetic dysfunctions of the surfactant system in children, therapy and outcomes of the disease.
Design: Multicentre, ambispective, open-label, descriptive pilot longitudinal study.
Materials and methods. We observed 17 children from 16 families with identified mutations in the SFTPC, ABCA3, NKX2-1 genes. Methods used: genealogical, Sanger sequencing, clinical exome sequencing, computed tomography and histological examination of the lungs.
Results. The study included 8 children with congenital deficiency of surfactant protein C, 8 children with brain-lung-thyroid syndrome and 1 patient with congenital deficiency of protein ABSA3. Based on the results of a genetic examination of patients, nucleotide variants c.218T>C were identified in 2 out of 8 patients with a mutation in the SFTPC gene, which is the most common according to the literature. In 5 children, the mutations were hereditary. Congenital deficiency of surfactant protein C, ABCA3 protein and brain-lung-thyroid syndrome were characterized by clinical, computed tomography, and morphological signs of interstitial lung disease. Despite complex respiratory, anti-inflammatory therapy, the frequency of deaths in congenital deficiency of surfactant protein C was 37.5%.
Conclusion. Children with severe respiratory distress syndrome of newborns, interstitial lung disease with the development of severe chronic respiratory failure, burdened with a family history should undergo genetic testing to detect mutations in the genes SFTPB, SFTPC, ABCA3. The patient's combination of respiratory symptoms with congenital hypothyroidism and neurological pathology is the basis for genetic examination for NKX2-1 gene mutations to exclude the brain-lung-thyroid syndrome
About the Authors
D. Yu. OvsyannikovRussian Federation
M. A. Zhestkova
Russian Federation
V. A. Strelnikova
Russian Federation
A. P. Averin
Russian Federation
Chelyabinsk
M. А. Atipaeva
Russian Federation
Chelyabinsk
O. Yu. Brunova
Russian Federation
G. V. Buyanova
Russian Federation
N. P. Weinstein
Russian Federation
M. V. Volchikhin
Russian Federation
I. V. Girutskaya
Russian Federation
I. V. Davydova
Russian Federation
D. A. Zhakota
Russian Federation
I. V. Kovalenko
Russian Federation
K. D. Korol
Russian Federation
Chelyabinsk
A. A. Kuznetsova
Russian Federation
A. A. Krushelnitsky
Russian Federation
Balashikha
A. B. Malakhov
Russian Federation
L. V. Malyutina
Russian Federation
E. A. Mamaeva
Russian Federation
T. V. Marshalkina
Russian Federation
Almaty
A. I. Migali
Russian Federation
A. V. Orlov
Russian Federation
A. Yu. Pastarnak
Russian Federation
S. I. Petrova
Russian Federation
Е. Е. Petryaikina
Russian Federation
Е. S. Petryaikina
Russian Federation
G. G. Prokopiev
Russian Federation
A. A. Pushkov
Russian Federation
K. V. Savostyanov
Russian Federation
Yu. A. Sigova
Russian Federation
D. A. Skobeev
Russian Federation
O. V. Sudakova
Russian Federation
Cherepovets
A. G. Talalaev
Russian Federation
O. G. Topilin
Russian Federation
M. A. Traube
Russian Federation
A. P. Fisenko
Russian Federation
A. Yu. Kholopova
Russian Federation
A. G. Tsverava
Russian Federation
N. B. Tsokova
Russian Federation
S. V. Cherkasova
Russian Federation
References
1. Nogee L.M. Genetic causes of surfactant protein abnormalities. Curr. Opin. Pediatr. 2019;31(3):330–9. DOI: 10.1097/MOP.0000000000000751
2. Singh J., Jaffe A., Schultz A., Selvadurai H. Surfactant protein disorders in childhood interstitial lung disease. Eur. J. Pediatr. 2021;180(9):2711–21. DOI: 10.1007/s00431-021-04066-3
3. Zhestkova M.A., Ovsyannikov D.Yu., Kuznetsova A.A., Avdeyev S.N. et al. Congenital deficiency of surfactant protein C: literature review and first clinical observations in the Russian Federation. Pediatria. Journal n.a. G.N. Speransky. 2019;98(3):265–73. (in Russian). DOI: 10.24110/0031-403X-
4. -98-3-265-2734. Abou Taam R., Jaubert F., Emond S., Le Bourgeois M. et al. Familial interstitial disease with I73T mutation: a mid- and long-term study. Pediatr. Pulmonol. 2009;44(2):167–75. DOI: 10.1002/ppul.20970.
5. Thouvenin G., Abou Taam R., Flamein F., Guillot L. et al.Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch. Dis. Child. 2010;95(6):449–54. DOI: 10.1136/adc.2009.171553
6. Doan M.L., Guillerman R.P., Dishop M.K., Nogee L.M. et al. Clinical,radiological and pathological features of ABCA3 mutations in children. Thorax. 2008;63(4):366–73. DOI: 10.1136/thx.2007.083766
7. Kurland G., Deterding R.R., Hagood J.S., Young L.R. et al. American Thoracic Society Committee on Childhood Interstitial Lung Disease(chILD) and the chILD Research Network. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am. J. Respir. Crit. Care Med. 2013;188(3):376–94. DOI: 10.1164/rccm.201305-0923ST
8. Gupta A., Zheng S.L. Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate. Arch. Dis. Child. 2017;102(1):84–90. DOI: 10.1136/archdischild-2012-303143
9. Edwards V., Cutz E., Viero S., Moore A.M. et al. Ultrastructure of lamellar bodies in congenital surfactant deficiency. Ultrastruct. Pathol. 2005;29(6):503–9. DOI: 10.1080/01913120500323480
10. Eldridge W.B., Zhang Q., Faro A., Sweet S. et al. Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism. J. Pediatr. 2017;184:157–64.e2. DOI: 10.1016/j.jpeds.2017.01.017
11. Liptzin D.R., Patel T., Deterding R.R. Chronic ventilation in infants with surfactant protein C mutations: an alternative to lung transplantation. Am. J. Respir. Crit. Care Med. 2015;191(11):1338–40. DOI: 10.1164/rccm.201411-1955LE
12. Williamson M., Wallis C. Ten-year follow up of hydroxychloroquine treatment for ABCA3 deficiency. Pediatr. Pulmonol. 2014;49:299–301. DOI: 10.1002/ppul.22811
13. hestkova M.A., Ovsyannikov D.Yu., Vasilievа T.G., Donin I.M. et al. Brain — lung —thyroid syndrome: literature review and series of clinical observations. Pediatria. Journal n.a. G.N. Speransky. 2019;98(5):85–93. (in Russian). DOI: 10.24110/0031-403X-2019-98-5-85-93
14. Bakhmetieva O.B., Nikolenko A.V., Biyanov A.N., Permyakova M.A. et al. The role of respiratory support in bronchopulmonary dysplasia development in extremely premature children with functional ductus arteriosus. Doctor.Ru. 2021;20(10):31–4. (in Russian). DOI: 10.31550/1727-2378-2021-20-10-31-34
15. Somaschini M., Presi S., Ferrari M., Vergani B. et al. Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome. J. Perinatol. 2018;38(4):337–44. DOI: 10.1038/s41372-017-0018-2
16. Chistiakov D.A., Savost'anov K.V., Turakulov R.I., Petunina N. et al. Further studies of genetic susceptibility to Graves' disease in a Russian population. Med. Sci. Monit. 2002;8(3):CR180–4.
Review
For citations:
Ovsyannikov D.Yu., Zhestkova M.A., Strelnikova V.A., Averin A.P., Atipaeva M.А., Brunova O.Yu., Buyanova G.V., Weinstein N.P., Volchikhin M.V., Girutskaya I.V., Davydova I.V., Zhakota D.A., Kovalenko I.V., Korol K.D., Kuznetsova A.A., Krushelnitsky A.A., Malakhov A.B., Malyutina L.V., Mamaeva E.A., Marshalkina T.V., Migali A.I., Orlov A.V., Pastarnak A.Yu., Petrova S.I., Petryaikina Е.Е., Petryaikina Е.S., Prokopiev G.G., Pushkov A.A., Savostyanov K.V., Sigova Yu.A., Skobeev D.A., Sudakova O.V., Talalaev A.G., Topilin O.G., Traube M.A., Fisenko A.P., Kholopova A.Yu., Tsverava A.G., Tsokova N.B., Cherkasova S.V. Genetic Dysfunctions of the Surfactant System in Children: Results of a Multicenter Study. PEDIATRICS. 2023;22(3):22-31. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-3-22-31